跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MICRO+6 CONCENTRATE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MICRO+6 CONCENTRATE
Authorized
STANDARD
MICRO+6 CONCENTRATE
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c23cb6a558651cef
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
c23cb6a558651cef
Drug Approval Canada Name
MICRO+6 CONCENTRATE
Product Name
MICRO+6 CONCENTRATE
Status
Marketed
Status Date
2021-06-18
Original Market Date
2021-06-18
Din
02507587
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
40:12.00
Atc Original
B05XA31 ELECTROLYTES IN COMB WITH OTHER DRUGS
Atc Name
b 05 xa 31
Aig Number
0631329007
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
CHROMIUM (CHROMIC CHLORIDE)
10 MCG / ML
COPPER (CUPRIC SULFATE)
300 MCG / ML
IODINE (SODIUM IODIDE)
75 MCG / ML
MANGANESE (MANGANESE SULFATE)
55 MCG / ML
SELENIUM (SELENIUM OXIDE)
60 MCG / ML
ZINC (ZINC SULFATE)
5 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c23cb6a558651cef
Type
Standard
Back to Health Canada Approvals